PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9336329-4	1997	In radioligand binding studies, ABT-089 was shown to display selectivity toward the high-affinity (-)-cytisine binding site present on the alpha4beta2 nAChR subtype (Ki = 16 nM) relative to the [125I]alpha-bungarotoxin binding site present on the alpha7 (Ki > or = 10,000 nM) and alpha1beta1deltagamma (Ki > 1000 nM) nAChR subtypes.	2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid	32-35	cholinergic receptor nicotinic alpha 4 subunit	Homo sapiens	151-156	
9336329-4	1997	In radioligand binding studies, ABT-089 was shown to display selectivity toward the high-affinity (-)-cytisine binding site present on the alpha4beta2 nAChR subtype (Ki = 16 nM) relative to the [125I]alpha-bungarotoxin binding site present on the alpha7 (Ki > or = 10,000 nM) and alpha1beta1deltagamma (Ki > 1000 nM) nAChR subtypes.	2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid	32-35	cholinergic receptor nicotinic alpha 4 subunit	Homo sapiens	323-328	
9336329-9	1997	The differential full agonist/partial agonist profile of ABT-089, as compared with (-)-nicotine and ABT-418, illustrates the complexity of nAChR activation and the potential to target responses at subclasses of the neuronal and peripheral receptors.	2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid	57-60	cholinergic receptor nicotinic alpha 4 subunit	Homo sapiens	139-144